0001415889-24-005674.txt : 20240228
0001415889-24-005674.hdr.sgml : 20240228
20240228125420
ACCESSION NUMBER: 0001415889-24-005674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240226
FILED AS OF DATE: 20240228
DATE AS OF CHANGE: 20240228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: De La Rosa Abel
CENTRAL INDEX KEY: 0001825983
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39811
FILM NUMBER: 24692743
MAIL ADDRESS:
STREET 1: 44 MILTON AVENUE
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Virios Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818844
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 854314201
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 44 MILTON AVENUE
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
BUSINESS PHONE: 8666208655
MAIL ADDRESS:
STREET 1: 44 MILTON AVENUE
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
FORMER COMPANY:
FORMER CONFORMED NAME: Virios Therapeutics, LLC
DATE OF NAME CHANGE: 20200721
4
1
form4-02282024_050213.xml
X0508
4
2024-02-26
0001818844
Virios Therapeutics, Inc.
VIRI
0001825983
De La Rosa Abel
C/O VIRIOS THERAPEUTICS, INC.
44 MILTON AVENUE
ALPHARETTA
GA
30009
true
false
false
false
0
Stock Option (right to buy)
0.357
2024-02-26
4
A
0
3959
0
A
2034-02-26
Common Stock
3959
3959
D
The stock option will vest 100% on February 26, 2025, one year following the grant date.
/s/ Greg Duncan, Attorney-in-Fact
2024-02-28